Ignite Creation Date:
2025-12-24 @ 5:38 PM
Ignite Modification Date:
2026-03-20 @ 9:35 AM
Study NCT ID:
NCT05824468
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-04-21
First Post:
2023-04-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Zimberelimab Plus Lenvatinib After Progression on Prior Immune Checkpoint Inhibitors for Advanced Cervical Cancer
Sponsor:
Sun Yat-sen University
Organization: